Vanguard Investments Australia
IRON icon

Vanguard Investments Australia’s Disc Medicine IRON Stock Holding History

Vanguard Investments Australia’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Hold
5,959
– – ﹤0.01% 1714
2026
Q1 		$381K Buy
+5,959
New +$414K ﹤0.01% 1719

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Investments Australia's IRON Position: Q2 2026 in Review

Vanguard Investments Australia held its Disc Medicine (IRON) position steady in Q2 2026 at 5,959 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #1714.

Vanguard Investments Australia first reported a position in IRON in Q1 2026 and has held it in 2 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Vanguard Investments Australia held 5,959 shares of Disc Medicine worth $436K as of Q2 2026.
  • Vanguard Investments Australia left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1714 holding.
  • Vanguard Investments Australia first reported a position in Disc Medicine in Q1 2026 and has held it in 2 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.